N@N

The Law Firm of Levi & Korsinsky, LLP Announces Investigation of SeraCare Life Sciences, Inc.

^{Published on 2011-06-23 15:50:28 - Market Wire}
 

NEW YORK--([ BUSINESS WIRE ])--Levi & Korsinsky is investigating the Board of Directors of SeraCare Life Sciences, Inc. (aSeraCarea or the aCompanya) (NASDAQ: SRLS) for possible breaches of fiduciary duty and other violations of state law in connection with the receipt of an unsolicited merger proposal from MSMB Capital. Under the terms of the transaction, SeraCare shareholders would receive $4.25 per share.

Click here to learn how to join the action: [ http://www.zlk.com/seracare-life-srls.html ], or call: 877-363-5972.

The investigation concerns whether the SeraCare Board of Directors is adequately shopping the Company and working to obtain the best price possible for SeraCare shareholders. In particular, SeraCare stock traded as high as $4.92 per share as recently as January 11, 2011. Furthermore, at least one analyst set a price target for SeraCare stock at $5.00 per share.

If you own common stock in SeraCare and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at [ jlevi@zlk.com ] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit [ http://www.zlk.com/seracare-life-srls.html ].

Levi & Korsinsky is a national firm with offices in New York, California and Washington D.C. The firm has extensive expertise in prosecuting investor securities litigation involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.